| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |